Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
NCT02588001
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Enzalutamide
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborators
[object Object]